Clinical Trial Update: N-acetylcysteine in the Treatment of Bulimia Nervosa [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating N-acetylcysteine for bulimia nervosa was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bulimia Nervosa

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Lindner Center of HOPE | Conditions: Bulimia Nervosa | Phase 3 | Status: TERMINATED